Alvin C. Powers, M.D. is the Joe C. Davis Chair in Biomedical Science Professor, Medicine, and Molecular Physiology and Biophysics. Director, Vanderbilt Diabetes Center. Director, Division of Diabetes and Endocrinology.Dr. Powers is a physician-scientist whose research on type 1 and type 2 diabetes focuses on pancreatic islet biology, development, and function. His research is or has been supported by the NIH, the VA Research Service, the JDRF, and the American Diabetes Association (ADA). Dr. Powers is also the Director of the Vanderbilt Medical Student Research Training Program in Diabetes, Endocrinology, and Metabolism and the Coordinator for the NIDDK Medical Student Research Program in Diabetes.

• Pathogenesis of type 1 diabetes: lessons from natural studies ofhigh-risk individuals 1Natalie Nokoff and Marian RewersThe role of reactive oxygen species and proinflammatorycytokines in type 1 diabetes pathogenesis 16Lindsey E. Padgett, Katarzyna, A. Broniowska, Polly A. Hansen,John A. Corbett and Hubert M. TseCardiovascular disease and glycemic control in type 2 diabetes:now that the dust is settling from large clinical trials 36Francesco Giorgino, Anna Leonardini and Luigi LaviolaType 2 diabetes in South Asians: similarities and differenceswith white Caucasian and other populations 51Unjali P. Guyral, R. Pradeepa, Mary Beth Weber, K.M. VenkatNarayan and V. MohanType 2 diabetes in East Asians: similarities and differenceswith population in Europe and the United States 64Ronald C.W. Ma and Juliana C.N. ChanIslet β cell mass in diabetes and how it relates tofunction, birth, and death 92Gordon C. Weir and Susan Bonner-WeirNanoalcoholic fatty liver disease: an emerging threat to obeseand diabetic individuals 106Howard C. Masuoka and Naga ChalasaniWhat is metabolic syndrome, and why are children getting it23Ram Weiss, Andrew A. Bremer and Robert H. LustigPhysical activity in obesity and metabolic syndrome 141Barbara StrasserHuman adipose dynamics and metabolic health 160Bin Feng, Tracy Zhang and Haiyan XuThe genetics of human obesity 178Qianghua Xia and Struan F.A. GrantManaging obesity in primary care practice: a narrative review191Raymond Carvajal, Thomas A. Wadden, Adam G. Tsai, KatherinePeck and Caroline H. Moran

Alvin C. Powers, M.D. is the Joe C. Davis Chair in Biomedical Science Professor, Medicine, and Molecular Physiology and Biophysics. Director, Vanderbilt Diabetes Center. Director, Division of Diabetes and Endocrinology.Dr. Powers is a physician-scientist whose research on type 1 and type 2 diabetes focuses on pancreatic islet biology, development, and function. His research is or has been supported by the NIH, the VA Research Service, the JDRF, and the American Diabetes Association (ADA). Dr. Powers is also the Director of the Vanderbilt Medical Student Research Training Program in Diabetes, Endocrinology, and Metabolism and the Coordinator for the NIDDK Medical Student Research Program in Diabetes.

• Pathogenesis of type 1 diabetes: lessons from natural studies ofhigh-risk individuals 1Natalie Nokoff and Marian RewersThe role of reactive oxygen species and proinflammatorycytokines in type 1 diabetes pathogenesis 16Lindsey E. Padgett, Katarzyna, A. Broniowska, Polly A. Hansen,John A. Corbett and Hubert M. TseCardiovascular disease and glycemic control in type 2 diabetes:now that the dust is settling from large clinical trials 36Francesco Giorgino, Anna Leonardini and Luigi LaviolaType 2 diabetes in South Asians: similarities and differenceswith white Caucasian and other populations 51Unjali P. Guyral, R. Pradeepa, Mary Beth Weber, K.M. VenkatNarayan and V. MohanType 2 diabetes in East Asians: similarities and differenceswith population in Europe and the United States 64Ronald C.W. Ma and Juliana C.N. ChanIslet β cell mass in diabetes and how it relates tofunction, birth, and death 92Gordon C. Weir and Susan Bonner-WeirNanoalcoholic fatty liver disease: an emerging threat to obeseand diabetic individuals 106Howard C. Masuoka and Naga ChalasaniWhat is metabolic syndrome, and why are children getting it23Ram Weiss, Andrew A. Bremer and Robert H. LustigPhysical activity in obesity and metabolic syndrome 141Barbara StrasserHuman adipose dynamics and metabolic health 160Bin Feng, Tracy Zhang and Haiyan XuThe genetics of human obesity 178Qianghua Xia and Struan F.A. GrantManaging obesity in primary care practice: a narrative review191Raymond Carvajal, Thomas A. Wadden, Adam G. Tsai, KatherinePeck and Caroline H. Moran

Alvin C. Powers, M.D. is the Joe C. Davis Chair in Biomedical Science Professor, Medicine, and Molecular Physiology and Biophysics. Director, Vanderbilt Diabetes Center. Director, Division of Diabetes and Endocrinology.Dr. Powers is a physician-scientist whose research on type 1 and type 2 diabetes focuses on pancreatic islet biology, development, and function. His research is or has been supported by the NIH, the VA Research Service, the JDRF, and the American Diabetes Association (ADA). Dr. Powers is also the Director of the Vanderbilt Medical Student Research Training Program in Diabetes, Endocrinology, and Metabolism and the Coordinator for the NIDDK Medical Student Research Program in Diabetes.

• Pathogenesis of type 1 diabetes: lessons from natural studies ofhigh-risk individuals 1Natalie Nokoff and Marian RewersThe role of reactive oxygen species and proinflammatorycytokines in type 1 diabetes pathogenesis 16Lindsey E. Padgett, Katarzyna, A. Broniowska, Polly A. Hansen,John A. Corbett and Hubert M. TseCardiovascular disease and glycemic control in type 2 diabetes:now that the dust is settling from large clinical trials 36Francesco Giorgino, Anna Leonardini and Luigi LaviolaType 2 diabetes in South Asians: similarities and differenceswith white Caucasian and other populations 51Unjali P. Guyral, R. Pradeepa, Mary Beth Weber, K.M. VenkatNarayan and V. MohanType 2 diabetes in East Asians: similarities and differenceswith population in Europe and the United States 64Ronald C.W. Ma and Juliana C.N. ChanIslet β cell mass in diabetes and how it relates tofunction, birth, and death 92Gordon C. Weir and Susan Bonner-WeirNanoalcoholic fatty liver disease: an emerging threat to obeseand diabetic individuals 106Howard C. Masuoka and Naga ChalasaniWhat is metabolic syndrome, and why are children getting it23Ram Weiss, Andrew A. Bremer and Robert H. LustigPhysical activity in obesity and metabolic syndrome 141Barbara StrasserHuman adipose dynamics and metabolic health 160Bin Feng, Tracy Zhang and Haiyan XuThe genetics of human obesity 178Qianghua Xia and Struan F.A. GrantManaging obesity in primary care practice: a narrative review191Raymond Carvajal, Thomas A. Wadden, Adam G. Tsai, KatherinePeck and Caroline H. Moran